141 related articles for article (PubMed ID: 32778523)
1. Apoptosis as an underlying mechanism in lymphocytes induced by riboflavin and ultraviolet light.
Hu H; Xu F; Yang W; Ren J; Ge W; Yang P
Transfus Apher Sci; 2020 Dec; 59(6):102899. PubMed ID: 32778523
[TBL] [Abstract][Full Text] [Related]
2. GADD45α is involved in the apoptosis of lymphocytes induced by riboflavin and ultraviolet light.
Yang P; Wen H; Zhong T; Hu H; Zhu B; Xia K; Xu M; Bian M
Transfusion; 2017 Mar; 57(3):646-656. PubMed ID: 27905125
[TBL] [Abstract][Full Text] [Related]
3. Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion.
Feys HB; Van Aelst B; Devreese K; Devloo R; Coene J; Vandekerckhove P; Compernolle V
Vox Sang; 2014 May; 106(4):307-15. PubMed ID: 24460692
[TBL] [Abstract][Full Text] [Related]
4. p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment.
Chen Z; Schubert P; Culibrk B; Devine DV
Transfusion; 2015 Apr; 55(4):848-57. PubMed ID: 25385501
[TBL] [Abstract][Full Text] [Related]
5. Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling.
Reid S; Johnson L; Woodland N; Marks DC
Transfusion; 2012 Oct; 52(10):2094-103. PubMed ID: 22320126
[TBL] [Abstract][Full Text] [Related]
6. p38 mitogen-activated protein kinase regulates mitochondrial function and microvesicle release in riboflavin- and ultraviolet light-treated apheresis platelet concentrates.
Chen Z; Schubert P; Bakkour S; Culibrk B; Busch MP; Devine DV
Transfusion; 2017 May; 57(5):1199-1207. PubMed ID: 28236306
[TBL] [Abstract][Full Text] [Related]
7. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
Smith J; Rock G
Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
[TBL] [Abstract][Full Text] [Related]
8. Real-time measurement of platelet shape change by light scattering under riboflavin and ultraviolet light treatment.
Terada C; Shiba M; Satake M; Tadokoro K
Transfusion; 2016 Mar; 56(3):587-95. PubMed ID: 26536611
[TBL] [Abstract][Full Text] [Related]
9. Pathogen reduction with riboflavin and ultraviolet light induces a quasi-apoptotic state in blood leukocytes.
Tran JQ; Muench MO; Heitman JW; Jackman RP
Transfusion; 2019 Nov; 59(11):3501-3510. PubMed ID: 31599981
[TBL] [Abstract][Full Text] [Related]
10. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study.
Picker SM; Steisel A; Gathof BS
Transfus Apher Sci; 2009 Apr; 40(2):79-85. PubMed ID: 19233725
[TBL] [Abstract][Full Text] [Related]
11. Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates.
Ambruso DR; Thurman G; Marschner S; Goodrich RP
Transfusion; 2009 Dec; 49(12):2631-6. PubMed ID: 19694996
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic function measured by thromboelastography and metabolic activity of platelets treated with riboflavin and UV light.
Ballester-Servera C; Jimenez-Marco T; Morell-Garcia D; Quetglas-Oliver M; Bautista-Gili AM; Girona-Llobera E
Blood Transfus; 2020 Jul; 18(4):280-289. PubMed ID: 32530405
[TBL] [Abstract][Full Text] [Related]
13. Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.
Balint B; Jovicic-Gojkov D; Todorovic-Balint M; Subota V; Pavlovic M; Goodrich R
Transfus Apher Sci; 2013 Dec; 49(3):434-9. PubMed ID: 23820430
[TBL] [Abstract][Full Text] [Related]
14. Photocatalytic interaction of aminophylline-riboflavin leads to ROS-mediated DNA damage and cell death: A novel phototherapeutic mechanism for cancer.
Khan S; Naseem I
IUBMB Life; 2017 Aug; 69(8):611-622. PubMed ID: 28636149
[TBL] [Abstract][Full Text] [Related]
15. Effects of riboflavin and ultraviolet light treatment on platelet thrombus formation and thrombus stability on collagen.
Terada C; Shiba M; Nagai T; Satake M
Transfusion; 2017 Jul; 57(7):1772-1780. PubMed ID: 28417457
[TBL] [Abstract][Full Text] [Related]
16. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
[TBL] [Abstract][Full Text] [Related]
17. Pathogen reduction treatment using riboflavin and ultraviolet light impairs platelet reactivity toward specific agonists in vitro.
Zeddies S; De Cuyper IM; van der Meer PF; Daal BB; de Korte D; Gutiérrez L; Thijssen-Timmer DC
Transfusion; 2014 Sep; 54(9):2292-300. PubMed ID: 24689812
[TBL] [Abstract][Full Text] [Related]
18. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
Bihm DJ; Ettinger A; Buytaert-Hoefen KA; Hendrix BK; Maldonado-Codina G; Rock G; Giclas PC; Goodrich RP
Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460
[TBL] [Abstract][Full Text] [Related]
19. [Ways of realizing apoptosis of human lymphocytes induced by UV-light and reactive oxygen species].
Artiukhov VG; Trubitsyna MS; Nakvasina MA; Solov'eva EV; Lidokhova OV
Radiats Biol Radioecol; 2011; 51(4):425-43. PubMed ID: 21950100
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.
Goodrich RP; Murthy KK; Doane SK; Fitzpatrick CN; Morrow LS; Arndt PA; Reddy HL; Buytaert-Hoefen KA; Garratty G
Transfusion; 2009 Jan; 49(1):64-74. PubMed ID: 18954398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
